Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Hemispherx BioPharma, Inc. (AMEX: HEB)
Sector: Medical
Current Price :
$0.20
52 Week Low
$0.19
52 Week High
$1.00
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
166M
Market Cap:
$0.04B
Avg Volume:
722328
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Hemispherx Biopharma (HEB) Gains After FDA Accepts Resubmission Regarding Ampligen NDA
Aug 14, 2012 09:15 AM |
HEB
Hemispherx And Fountain To Start China Trial Of Flu Drug
May 26, 2010 02:55 PM |
HEB
Market Closing Update: Flat Finish For Wall Street As Energy Shares Weigh
Dec 02, 2009 04:50 PM |
HEB
,
NOK
,
NVAX
More Articles on HEB..
Press Releases
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2013
May 08, 2013 03:54 PM |
HEB
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2012
Mar 18, 2013 03:24 PM |
HEB
Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in Argentina
Mar 04, 2013 08:01 AM |
HEB
More Press Releases on HEB..
SEC Filings
Form 4 HEMISPHERX BIOPHARMA For: Jan 15 Filed by: CARTER WILLIAM A (10K)
Jan 16, 2013 01:22 PM
Form 4 HEMISPHERX BIOPHARMA For: Dec 19 Filed by: CARTER WILLIAM A (10K)
Dec 21, 2012 10:51 AM
Form 4 HEMISPHERX BIOPHARMA For: Nov 20 Filed by: CARTER WILLIAM A (10K)
Nov 21, 2012 04:24 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
HEB
Compare to S&P
YTD
-13.88 %
-21.02 %
4 Weeks
8.00 %
8.11 %
12 Weeks
-15.29 %
-18.14 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
0.00 %
EPS Growth in Last Year:
0.00 %
Sales Growth in Last Quarter:
133.33 %
Sales Growth in Last Quarter:
84.21 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##